Literature DB >> 9639558

Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.

U Kishore1, L E Leigh, P Eggleton, P Strong, M V Perdikoulis, A C Willis, K B Reid.   

Abstract

The first step in the activation of the classical pathway of the complement system by immune complexes involves the binding of the six globular heads of C1q to the Fc regions of IgG or IgM. The globular heads of C1q are located C-terminal to the six triple-helical stalks present in the molecule; each head is considered to be composed of the C-terminal halves (3x136 residues) of one A-, one B- and one C-chain. It is not known if the C-terminal globular regions, present in each of the three types of chain, are independently folded modules (with each chain having distinct binding properties towards immunoglobulins) or whether the different binding functions of C1q are dependent upon a globular structure which relies on contributions from all three chains. As a first step towards addressing this question, we have expressed the globular head region (residues 87-226) of the C1q B-chain (ghB) as a soluble fusion protein with maltose-binding protein (MBP) in Escherichia coli. The affinity purified fusion protein, designated MBP-ghB, behaved as a dimer on gel filtration and bound preferentially to aggregated IgG rather than to IgM. It could also inhibit C1q-dependent haemolysis of both IgG- and IgM-sensitized erythrocytes. After its release from MBP, by use of Factor Xa, the free ghB exhibited a tendency to aggregate and come out of solution. Since MBP is known to be a monomeric molecule, the dimerization of the MBP-ghB fusion polypeptide is probably brought about by the ghB region, perhaps through hydrophobic interactions within the ghB region. The functional behaviour of MBP-ghB indicates that the globular regions of C1q may adopt a modular organization, i.e. each globular head of C1q may be composed of three structurally and functionally independent domains, thus retaining multivalency in the form of a heterotrimer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639558      PMCID: PMC1219551          DOI: 10.1042/bj3330027

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  An immune complex selective affinity matrix utilizing a synthetic peptide.

Authors:  M A Baumann; B E Anderson
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

2.  Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation.

Authors:  S J Perkins; A S Nealis; B J Sutton; A Feinstein
Journal:  J Mol Biol       Date:  1991-10-20       Impact factor: 5.469

Review 3.  Models for the C1 complex determined by physical techniques.

Authors:  S J Perkins
Journal:  Behring Inst Mitt       Date:  1989-07

4.  The cloning and sequencing of alpha 1(VIII) collagen cDNAs demonstrate that type VIII collagen is a short chain collagen and contains triple-helical and carboxyl-terminal non-triple-helical domains similar to those of type X collagen.

Authors:  N Yamaguchi; P D Benya; M van der Rest; Y Ninomiya
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

5.  Hibernation-associated gene regulation of plasma proteins with a collagen-like domain in mammalian hibernators.

Authors:  N Takamatsu; K Ohba; J Kondo; N Kondo; T Shiba
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q.

Authors:  G C Sellar; D J Blake; K B Reid
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

7.  Precerebellin is a cerebellum-specific protein with similarity to the globular domain of complement C1q B chain.

Authors:  Y Urade; J Oberdick; R Molinar-Rode; J I Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

8.  Beta-sheet secondary structure of the trimeric globular domain of C1q of complement and collagen types VIII and X by Fourier-transform infrared spectroscopy and averaged structure predictions.

Authors:  K F Smith; P I Haris; D Chapman; K B Reid; S J Perkins
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G.

Authors:  G Marqués; L C Antón; E Barrio; A Sánchez; S Ruiz; F Gavilanes; F Vivanco
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

10.  Physical characterization and crystallization of the carbohydrate-recognition domain of a mannose-binding protein from rat.

Authors:  W I Weis; G V Crichlow; H M Murthy; W A Hendrickson; K Drickamer
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

View more
  14 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins.

Authors:  J D Fox; R B Kapust; D S Waugh
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

Review 3.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

4.  Interaction of alpha-agglutinin and a-agglutinin, Saccharomyces cerevisiae sexual cell adhesion molecules.

Authors:  H Zhao; Z M Shen; P C Kahn; P N Lipke
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

5.  Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Authors:  Heping Cao; Frederick Dzineku; Perry J Blackshear
Journal:  Arch Biochem Biophys       Date:  2003-04-01       Impact factor: 4.013

6.  Contribution of chondroitin sulfate A to the binding of complement proteins to activated platelets.

Authors:  Osama A Hamad; Per H Nilsson; Maria Lasaosa; Daniel Ricklin; John D Lambris; Bo Nilsson; Kristina Nilsson Ekdahl
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

7.  Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains.

Authors:  Lubka T Roumenina; Marieta M Ruseva; Alexandra Zlatarova; Rohit Ghai; Martin Kolev; Neli Olova; Mihaela Gadjeva; Alok Agrawal; Barbara Bottazzi; Alberto Mantovani; Kenneth B M Reid; Uday Kishore; Mihaela S Kojouharova
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

8.  Screening and analysis of PoAkirin1 and two related genes in response to immunological stimulants in the Japanese flounder (Paralichthys olivaceus).

Authors:  Chang-Geng Yang; Xian-Li Wang; Bo Zhang; Bing Sun; Shan-Shan Liu; Song-Lin Chen
Journal:  BMC Mol Biol       Date:  2013-05-07       Impact factor: 2.946

9.  Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR.

Authors:  Lina Pednekar; Ansar A Pathan; Basudev Paudyal; Anthony G Tsolaki; Anuvinder Kaur; Suhair M Abozaid; Lubna Kouser; Haseeb A Khan; Ellinor I Peerschke; Mohamed H Shamji; Gudrun Stenbeck; Berhane Ghebrehiwet; Uday Kishore
Journal:  Front Immunol       Date:  2016-12-13       Impact factor: 7.561

10.  A C1q domain containing protein from scallop Chlamys farreri serving as pattern recognition receptor with heat-aggregated IgG binding activity.

Authors:  Leilei Wang; Lingling Wang; Huan Zhang; Zhi Zhou; Vinu S Siva; Linsheng Song
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.